---
schema_version: "secwatch.filing_event.v1"
accession: "0001553350-22-000088"
form_type: "8-K"
ticker: "PDEX"
cik: "0000788920"
company_name: "PRO DEX INC"
filed_at: "2022-02-03T23:59:59+00:00"
generated_at: "2026-06-27T12:01:56.199901+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pro-Dex Q2 net sales up 23% to $10.2M but net income falls to $0.25 EPS from $0.44

## Summary
- Q2 net sales $10.2M (+23% YoY) driven by orthopedic surgical handpiece sales to largest customer.
- Net income $925K ($0.25 diluted EPS) vs $1.8M ($0.44) prior year; six-month net income $2.0M ($0.52).
- Supply chain challenges worsening; expects negative impact on net sales in Q3 and possibly Q4 FY2022.
- Internal product launches delayed as resources shifted to customer non-recurring engineering projects.
- R&D spend $615K in Q2; ENT Shaver launch expected Q4 2022 ($1M est annual revenue), Vital Ventilator Q1 2023 ($1.5M est).

## SEC filing metadata
- accession: 0001553350-22-000088
- form_type: 8-K
- ticker: PDEX
- cik: 0000788920
- company_name: PRO DEX INC
- filed_at: 2022-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/788920/000155335022000088/0001553350-22-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/788920/000155335022000088/pdex_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001553350-22-000088
- JSON: https://secwatch.observer/filing/0001553350-22-000088.json
- Plain text: https://secwatch.observer/filing/0001553350-22-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.